Who it is for
- A BMI of 30 or more
- A BMI of 27 or more with type 2 diabetes, high blood pressure, sleep apnoea, joint pain or another weight-related illness
- You have tried diet and exercise and need more help
What happens
- A doctor's assessment by video: your history, medicines and goals
- Blood tests before any medicine: HbA1c, cholesterol, kidneys, liver and thyroid
- Medicine where it is safe for you, delivered sealed to your door
- Your dietitian every two weeks: a protein target, meals you already eat, and strength exercise
- A doctor's review every month before any refill
- A full review at six months
When it is not working
If you have lost less than 5% of your weight after six months on the full dose you tolerate, the doctor changes the plan rather than continuing. That can mean a different medicine, a gastric balloon, or, if you qualify, an assessment for weight loss surgery.
Why the dietitian is part of it
Up to a third or more of the weight lost on weight loss injections can be muscle unless you eat enough protein and do strength exercise. Most people also regain much of the weight within a year of stopping. The dietitian works on both from the start.
Not sure this is the right programme?
The free check takes two minutes, needs no name, and gives you one next step.
Take the free checkQuestions people ask
Do I need a referral?
No. Take the free check or book the assessment directly.
Is it all by video?
The doctor and dietitian see you by video anywhere in Nigeria. Blood tests are at a partner lab near you, or at home in Lagos.
How long does it last?
Six months, then a full review. Many people continue for a year or more; some move to maintenance without medicine.
Does my HMO pay?
Most Nigerian HMO plans do not cover weight loss medicine. Bring your HMO number and the desk will ask before anything is billed.
Then, if it suits you: ₦75,000 a month, plus the medicine.
Reviewed by Dr Debo Odulana on 2 November 2026. This page is information, not a prescription: a doctor decides what is safe for you.
- Overweight and obesity management (NG246), National Institute for Health and Care Excellence (NICE), 2025
- Tirzepatide for managing overweight and obesity (TA1026), NICE, 2024
- Semaglutide for managing overweight and obesity (TA875), NICE, 2023
- Continued treatment with tirzepatide for maintenance of weight reduction (SURMOUNT-4), JAMA, 2024